Company news

Crossject SA news in 2026

Crossject SA's news releases, calls and decks from 2026, newest first.

View company

CROSSJECT structure sa gouvernance pour la phase de déploiement industriel et commercial

September 24, 2026

CROSSJECT strengthens its governance for the industrial and commercial deployment phase

September 24, 2026

CROSSJECT publie ses résultats du premier semestre 2026 et présente une structure financière profondément renforcée

September 24, 2026

CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure

September 25, 2026

CROSSJECT publie ses résultats du premier semestre 2026 et présente une structure financière profondément renforcée

September 24, 2026

CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030

September 23, 2026

Information relative au nombre total de droits de vote et d'actions composant le capital social

July 20, 2026

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million

May 22, 2026

CROSSJECT appoints Lionel Seltz as Chief Financial Officer

March 25, 2026

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory

March 25, 2026

CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)

February 2, 2026

Decks in 2026